Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Items 401–500 of 749
Zhou, Z., Feng, Z., Sun, X., Wang, Y., & Dou, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115516 · Cited by 9
Sun, X., Chen, C., Liu, H., & Tang, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10847 · Cited by 9
Examining the Relationship Between Diabetic Macular Edema, and Obstructive Sleep Apnea
Kaba, Q., Tai, F., Al-Awadi, A., & Somani, S. (2022) · Clinical ophthalmology · doi:10.2147/opth.s354087 · Cited by 9
Evidence for Paracrine Protective Role of Exogenous αA-Crystallin in Retinal Ganglion Cells
Nath, M., Sluzala, Z. B., Phadte, A. S., Shan, Y., Myers, A. M., & Fort, P. E. (2022) · eNeuro · doi:10.1523/eneuro.0045-22.2022 · Cited by 9
“They are also reported to be involved in the inflammation associated with the pathophysiology of diabetic retinopathy (DR), with special emphasis on the March/April 2022, 9(2) ENEURO.0045-22.2022 eNeuro.org functional relationships between glial cells and neurons (Rübsam et al., 2018).”
BackgroundSelf-citationHarnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?
Ameln, A. K., & Sprott, D. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02695-7 · Cited by 9
Poyil, N. J. T., Vadakkekuttical, R. J., & Radhakrishnan, C. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i4.686 · Cited by 14
Garg, D., & Daigavane, S. V. (2024) · Cureus · doi:10.7759/cureus.69651 · Cited by 11
“Specifically, PBM has been found to lower the expression of vascular endothelial growth factor, a key player in the development of DR [19].”
BackgroundLin, C., Wu, M.-R., Tanasă, B., Prakhar, P., Deng, B., Davis, A. E., Li, L., Xia, A., Shan, Y., Fort, P. E., et al. (2024) · Diabetes · doi:10.2337/db24-0199 · Cited by 9
Self-citationWang, Z., Wang, H., Chen, Y., Chen, Y., Zhang, X., Diwon, A., Zhang, G., Sheng, Q., Mei, H., Xu, Y., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00874-0 · Cited by 8
Oliveira, S., Guimarães, P., Campos, E. J., Fernandes, R., Martins, J., Castelo-Branco, M. S., Serranho, P., Matafome, P. N., Bernardes, R. C., & Ambrósio, A. F. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.1.7 · Cited by 11
Wang, L., Liu, L., Luo, H., Wu, Y., & Zhu, L. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s504308 · Cited by 9
D’Angelo, A., Lixi, F., Vitiello, L., Gagliardi, V., Pellegrino, A., & Giannaccare, G. (2025) · BioMed Research International · doi:10.1155/bmri/6654976 · Cited by 11
The Ambiguous Role of HMGB1 Across the Hallmarks of Aging: A Narrative Review
Ning, M., Liang, Y., Zhang, L., Wang, F., & He, L. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s550572 · Cited by 8
“53 The HMGB1-CTSB-LMP axis disrupts lysosomal stability under high-glucose conditions, characterized by excessive CTSB release, impaired lysosomal acidification, and reduced cathepsin activity.”
Mohamed, M. K., Atef, A. A., Moemen, L. A., Azeem, A. A. A., Mohalhal, I. A., & Taha, A. M. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00401-9 · Cited by 9
“Several biomarkers have been identified to be associated with endothelial dysfunction in DR, such as oxidative stress through the production of advanced glycosylation end products (AGEP), chronic inflammation [18, 19], and dysregulated growth factors and cytokines [19, 20].”
BackgroundAltered Functionality of Lipoprotein(a) Impacts on Angiogenesis in Diabetic Retinopathy
Shariatzadeh, M., Nagtzaam, N. M. A., der Zee, L. V. V., van Holten-Neelen, C., Verhoeven, A. J. M., Dehairs, J., Swinnen, J. V., Leijten, F. P. J., ten Berge, J. C., Ciriano, J. P. M., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.5.8 · Cited by 8
“In our relatively small cohort of patients, we could not find any association between the circulating Lp(a) concentration and different stages of DR. Similarly, Singh et al. 17 found no association between Lp(a) level and development of DR in a large cohort of controls and patients of European descent.”
InfluentialHuang, Y.-T., Steptoe, A., Patel, R. S., Thomson, E. F., & Cadar, D. (2023) · Gerontology · doi:10.1159/000531848 · Cited by 8
“The retinopathy/eye diseases in this study included four age-related conditions: diabetic retinopathy, macular degeneration, glaucoma, and cataract, and they are closely or partially related to inflammation [34-37] that might influence the risk of COVID-19 infection.”
BackgroundThe significance of glutaredoxins for diabetes mellitus and its complications
Zhou, M., Hanschmann, E.-M., Römer, A., Linn, T., & Petry, S. F. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103043 · Cited by 11
“The mechanisms of DR are mostly studied in terms of inflammation [216], apoptosis [217], vascular dysfunction [218], and destruction of neurovascular units [219].”
BackgroundChbel, A., Lafnoune, A., Irahal, I. N., & Bourhim, N. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.004 · Cited by 10
Fu, S., Zhou, Q., Peng, X., Hu, Y., Xiong, J. P., & Liu, F. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.106972 · Cited by 10
Singer, M. A., Wykoff, C. C., & Grewal, D. S. (2020) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20201104-10 · Cited by 8
Galectins in the Pathogenesis of Common Retinal Disease
Caridi, B., Doncheva, D., Sivaprasad, S., & Turowski, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.687495 · Cited by 10
“In diabetes, Müller glia present with enhanced levels of AGE receptors and enhanced production of cytokines, including TNF-α, IL-1β, IL-6, MCP1, nitric oxide and VEGF (Rübsam et al., 2018; Shin et al., 2014; Xu et al., 2018).”
BackgroundCarroll, L. S., Uehara, H., Fang, D., Choi, S., Zhang, X., Singh, M. K., Sandhu, Z., Cummins, P. M., Curtis, T. M., Stitt, A. W., et al. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26182 · Cited by 9
Li, X., Qin, W., Qin, X., Wu, D., Gao, C., Luo, Y., & Xu, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1320632 · Cited by 7
Huang, C., Zhang, X., Wu, M., Chen, Y., Ge, X., Chen, W., Li, X., Liu, S., & Yang, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113611 · Cited by 10
Kadavil, H., Adib, S. S. A., Marei, A., Al-Qahtani, N. H. S., Zhu, Y., Al-Kinani, A. A., Alany, R. G., & Younes, H. M. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2516668 · Cited by 9
Zhong, J., Yao, C., & Jin, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1615045 · Cited by 8
“Müller cells, astrocytes, and RPE cells subsequently amplify the inflammation response (6, 48).”
Sun, T., Li, X., Zhu, J., Yao, W., Yang, T., Meng, X.-R., Yao, J., & Jiang, Q. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10994 · Cited by 7
“As is well known to us all, the balance of reactive glial cells is important for neuron survival as reactive glial cells can produce growth factors and immunomodulatory cytokines [25].”
BackgroundZhang, Y. S., Taha, A. T., Thompson, I. J. B., Keenan, J. D., Yang, D., Wu, J. H., & Stewart, J. M. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.11.30 · Cited by 8
“56 Haq et al. have previously demonstrated higher concentrations of aqueous markers of inflammation in male patients with diabetes, indicating a heightened inflammatory state as another potential cause of more severe DR in men.”
BackgroundQayyum, S., Afzal, M., Naveed, A. K., Butt, I. A., Sajjad, M., & Azam, M. (2023) · Journal of the Pakistan Medical Association · doi:10.47391/jpma.6072 · Cited by 7
Regu, V. R., Gohel, V., Gaur, M., Swain, R. P., Das, J., & Subudhi, B. B. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124265 · Cited by 8
Complement Factor C1q Mediates Vascular Endothelial Dysfunction in STZ-Induced Diabetic Mice
Mao, A., Li, Z., Shi, X., Zhang, K., Kan, H., Geng, L., & He, D. (2024) · Diabetes · doi:10.2337/db23-0981 · Cited by 7
Serum inflammation biomarkers level in cystoid and diffuse diabetic macular edema
Liao, W., Liu, F., Liu, W., & Xiao, C. (2024) · International Ophthalmology · doi:10.1007/s10792-024-03372-7 · Cited by 7
“Previous studies have shown that inflammation had an essential role in different stages of DR [25, 26].”
Amin, R., Indiarsih, T. B., Sari, P. M., & Purwanita, P. (2022) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.11.3.394 · Cited by 10
Ye, X., Xiang, F., & Hu, Y. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-6591 · Cited by 7
“A study has shown that the increased apoptosis of retinal microvascular pericytes and endothelial cells under high glucose conditions can lead to negative effects on the retinal microvascular system and also induced a variety of inflammatory responses (10).”
BackgroundRetractedZakerkish, M., Raeisi, D., Rafie, S., Yazdi, M. J. S., Kosarian, Z., Telegrafchi, S. R., & Hesam, S. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0043 · Cited by 8
“Ischemia, perivascular inflammation, persistent hyperglycemia, Nerve growth factor (NGF) and Nerve growth factor (NGF) have emerged as potential players in the pathogenesis of diabetic neuropathy [3-5].”
BackgroundRamsay, E., Raviña, M., Sarkhel, S., Hehir, S., Cameron, N. R., Ilmarinen, T., Skottman, H., Kjems, J., Urtti, A. O., Ruponen, M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070667 · Cited by 8
The Correlation of Inflammation and Microvascular Changes with Diabetic Retinal Neurodegeneration
Buyuktepe, T. C., Demirel, S., Batıoğlu, F., & Özmert, E. (2021) · Current Eye Research · doi:10.1080/02713683.2021.1908567 · Cited by 7
Nguyen, Q. D., Ehlers, J. P., Boyer, D. S., Jin, X., Giani, A., Ehrlich, M. S., On behalf of the ROBIN study investigators, Brucker, A. J., Hu, A. Y. H., Fawzi, A. A., et al. (2024) · Eye · doi:10.1038/s41433-024-03017-0 · Cited by 6
“DR is the result of chronic damage to retinal neurovascular structures and can lead to irreversible vision loss [1, 2]; changes in inflammation play a key role in the development of DR [18].”
BackgroundParashar, R., & Suresh, P. K. (2025) · Drug Delivery · doi:10.1080/10717544.2025.2509973 · Cited by 7
“…occurs in the retinal microvasculature, leading to vascular compromise and retinal damage. adhesion molecules, such as icaM-1, play a crucial role in leukostasis by promoting the adhesion of wBcs to the endothelial cells of blood vessels (Suryavanshi and Kulkarni 2017; Rübsam et al. 2018).”
Interpretable transfer learning framework for diabetic retinopathy stage classification
Bouabidi, D., & Echtioui, A. (2025) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-025-00604-3 · Cited by 6
Kumari, N., Barman, S., & Ganesan, S. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05546-5 · Cited by 9
“Reactive astrocytes upregulate GFAP [26] and secrete IL-1β, TNF-α, VEGF, and nitric oxide which creates a hostile environment for bipolar cell terminals, impairing synaptic transmission [115, 129].”
Gao, Y., Xue, M., Dai, B., Tang, Y., Liu, J., Zhao, C., Hu, M., Yan, F., Zhu, X., Lu, Y. W., et al. (2023) · BMC Ophthalmology · doi:10.1186/s12886-023-02774-y · Cited by 6
“Thus, the morphological and molecular alterations in DR caused by these two processes are receiving great attention, becoming the focus of extensive research [7, 8].”
BackgroundManaging Diabetic Complications with Alternative Therapeutic Strategies
Srivastava, S. P., Upadhyay, P., Das, S., Tiwari, N., Mishra, S. K., & Tripathi, S. M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230907112430 · Cited by 12
Mgwenya, T. N., Abrahamse, H., & Houreld, N. N. (2024) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/photob.2024.0041 · Cited by 6
Jiang, S., & Han, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1422787 · Cited by 7
Liao, Q., & Gao, X. (2022) · Bioengineered · doi:10.1080/21655979.2022.2056315 · Cited by 6
“Inflammatory response and oxidative stress are commonly acknowledged as primary contributors of DR [30,31].”
BackgroundMaghbooli, Z., Meimand, S. E., Hosseini, A.-A. M., & Shirvani, A. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01084-6 · Cited by 7
Chan‐Ling, T., Hu, P., Calzi, S. L., Warner, J., Uddin, M. N., Dupont, M., Neuringer, M. D., Kievit, P., Renner, L. M., Stoddard, J., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.02.019 · Cited by 6
Xanthine derivative KMUP-1 ameliorates retinopathy
Yeh, J., Kuo, C., Shih, P.-W., Hsu, J., Peng, I., & Huang, Y.-H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115109 · Cited by 6
Liu, Z., Liu, W., Han, M., Wang, M., Li, Y., Yao, Y., & Duan, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155334 · Cited by 6
Chen, X., Yang, W., Fong, A. H., Chahal, N., Taha, A. T., Keenan, J. D., & Stewart, J. M. (2024) · Ophthalmology Science · doi:10.1016/j.xops.2024.100580 · Cited by 6
Wang, D., & Liu, R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03360-9 · Cited by 11
“Thus, IL-35 inhibited the development of Th17 cells and decreased the production of IL-17 by suppressing the expression of ROR γt and ROR α, thereby contributing to the reduction of PDR.”
InfluentialCorrelation between metabolic status and diabetic retinopathy evolution in type 1 diabetes
Romila, A., Potop, V., Ciuluvica, R. C., Monica, B., Hîncu, M. C., & Jurja, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10648 · Cited by 6
“The factors that lead to changes in diabetic retinopathy, generated mainly by insulin deficiency and consequent hyper‐ glycemia are: Increased hemoglobin compared to normal by 10‐20%, which blocks the release of oxygen; the increase of intracellular sorbitol which leads to the increase of the osmotic pressure and to t…”
BackgroundAljundi, W., Suffo, S., Munteanu, C., Langenbucher, A., Seitz, B., & Abdin, A. (2022) · Clinical ophthalmology · doi:10.2147/opth.s346065 · Cited by 6
“The importance of inflammation in this context has been supported by the fact that blocking inflammation reduces neovascularization.(23) These pathophysiological facts explain the long-standing use of steroids to treat DME and support our assumption that steroids may play a further role in the treatment of PDR.”
BackgroundSarmah, D. T., Gujjar, S., Mathapati, S., Bairagi, N., & Chatterjee, S. (2023) · Gene · doi:10.1016/j.gene.2023.147339 · Cited by 6
ASK1 induces retinal microvascular endothelial cell apoptosis through ER stress-associated pathway.
Zou, W., Zou, C., Zhao, M., & Zheng, Z. J. (2019) · Europe PMC (PubMed Central) · Cited by 6
Rishi, P., Verma, A., Akhtar, Z., Agrawal, R. V., Agrawal, A., Bharat, R. P. K., & Rishi, E. (2021) · Oman Journal of Ophthalmology · doi:10.4103/ojo.ojo_7_21 · Cited by 6
Global research trends and hotspots of oxidative stress in diabetic retinopathy (2000-2024)
Du, K., Liu, Y., Zhao, X., Wang, H., Wan, X., Sun, X., & Luo, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1428411 · Cited by 6
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in mice
Rossi, G. D., Qiu, A.-W., Berg, M., Burgoyne, T., Martello, A., Lobo, M. E. D. V., Rizzi, M., Mueller, S., Blackburn, J. W. D., Meng, Y., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adn6047 · Cited by 9
“Critically, both inflammatory pathways are active in human diabetic retinas (26).”
Adhikary, P., Maddheshiya, A., Takkar, B., Das, T., & Mukherjee, S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113043 · Cited by 7
Puerarin as potential treatment in diabetic retinopathy
Fathalipour, M., Mahmoodzadeh, A., Safa, O., & Mirkhani, H. (2020) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.2020.14 · Cited by 5
Long-term aspirin administration suppresses inflammation in diabetic cystopathy
Du, H., Xu, F., Liu, J., Zhang, J., Qin, Y., Xu, Y., & Li, N. (2023) · Aging · doi:10.18632/aging.205021 · Cited by 5
Liu, R., Zhang, J., Gu, W., Zhao, X., Xiao, L., & Yang, C. (2024) · BMC Ophthalmology · doi:10.1186/s12886-024-03303-1 · Cited by 5
“Considering that DR is clearly connected with inflammation [26, 27], and DII serves as a tool to quantify the inflammatory potential of the diet, there is good reason to believe that DII is theoretically associated with DR.”
BackgroundPeptain-1 blocks ischemia/reperfusion-induced retinal capillary degeneration in mice
Nam, M., Dhillon, A., Nahomi, R. B., Carrillo, N., Hougen, C., & Nagaraj, R. H. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1441924 · Cited by 5
The MDM2-p53 axis regulates norrin/frizzled4 signaling and blood-CNS barrier function
Levey, J., Abedin, M. J., Zhang, C., Odame, E., Zhang, L., Jo, H., Douglas, K., Roehrich, H., Chen, Z., & Junge, H. J. (2025) · Science Signaling · doi:10.1126/scisignal.adt0983 · Cited by 5
Role of epicardial fat thickness for prediction of proliferative diabetic retinopathy
Abide, S., Tuba, K., Alkan, Y., Coşgun, M., Umit, D., Ulaş, F., Güneş, Y., & Sıncer, İ. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-01040-5 · Cited by 6
Zhang, M., Dong, Z., Dong, W., Zhou, D., & Ren, X. S. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11610 · Cited by 6
Kolomeyer, A. M., Eichenbaum, D. A., Kiernan, D. F., Suñer, I. J., & Hariprasad, S. M. (2023) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20230215-01 · Cited by 5
Zhu, X., Wang, Y., Cheng, L., & Kuang, H. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.10.11 · Cited by 6
“For screening the most effective lnNEAT1 shRNA, three shRNAs were designed and sh-NEAT1 (2) had the best effect, so the experiment was subsequently performed using this shRNA (Fig.”
MethodTHE INFLUENCE OF A BENZODIAZEPINE RECEPTOR AGONIST ON THE STATE OF GLIA IN THE DIABETIC RETINOPATHY
Zyablitzev, S. V., Zhupan, D. B., & Dyadyk, O. (2023) · Fìzìologìčnij žurnal · doi:10.15407/fz69.06.033 · Cited by 5
Yang, Y., Liu, Y., Tang, H., Zhou, Q., Li, H., & Song, E. (2024) · Current Eye Research · doi:10.1080/02713683.2024.2337301 · Cited by 6
“7 Sphingosine-1-phosphate (S1P), a signaling lipid, plays crucial roles in a wide variety of cellular functions, including cell growth and survival, angiogenesis, proliferation, neurito-genesis, cell motility and migration, and lymphocyte trafficking.”
Huang, Z., Chen, L. J., Huang, D., Yi, J., Chen, Z., Lin, P., Wang, Y., Zheng, J., & Chen, W. (2024) · Journal of Diabetes Research · doi:10.1155/2024/2550367 · Cited by 6
Amin, R., Hidayat, R., Maritska, Z., & Putri, T. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s490055 · Cited by 8
The Potential Beneficial Effects of Curcumin in Diabetic Retinopathy
Nawaz, M. I., Alhomida, A. S., & Ola, M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00022-0 · Cited by 5
Post-cataract Cystoid Macular Oedema Prevention – Update 2019
Grzybowski, A. E., Žemaitienė, R., & Mikalauskiene, L. (2019) · European Ophthalmic Review · doi:10.17925/eor.2019.13.1.37 · Cited by 5
Yu, J., Daw, J., Portillo, J. C., & Subauste, C. S. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.12.22 · Cited by 5
Wei, J., Xiang, X.-H., Tang, Y., Qin, D., Wu, J., Yu, C., Qiu, W., Wu, A., & Lv, H. (2021) · Food and Agricultural Immunology · doi:10.1080/09540105.2021.1968352 · Cited by 5
“Emerging evidence indicates that the pro-inflammatory responses in Müller cells aggravate BRB damage (Rübsam et al., 2018).”
BackgroundDeuchler, S., Schubert, R., Singh, P. K., Chedid, A., Kenikstul, N., Scott, J., Kohnen, T., Ackermann, H., & Koch, F. (2022) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-022-05564-2 · Cited by 5
“Corticosteroids are multi-factorial in nature and target VEGF and several inflammatory cytokines relating to the development of DR and DME [6].”
BackgroundKunder, M., Lakshmaiah, V., & Kutty, A. V. M. (2022) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_1293_19 · Cited by 6
Th22 Cells Induce Müller Cells Activation Via the Act1/Traf6 Pathway in Diabetic Retinopathy
Wang, Y., Yu, H., Li, J., Liu, W., Yu, S., Lv, P., Zhao, L., Wang, X., Zuo, Z., & Liu, X. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03689-8 · Cited by 7
Alswailmi, F. K. (2023) · Pharmaceuticals · doi:10.3390/ph16030345 · Cited by 6
Breaking the ocular barrier through nano-lipid carriers to treat intraocular diseases
Giri, S., Badwaik, H. R., & Giri, T. K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104867 · Cited by 5
Vascular endothelial growth factor +405G/C polymorphism as a predictor of diabetic retinopathy
Amer, A. K., Khalaf, N. A., Aboelmakarem, S. H., Elsobky, M. S., Abdelrasoul, M. R., Abdelazeem, A. A., Noweir, S. R., Refaat, S., Moemen, L. A., Mohammed, S. A., et al. (2020) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-020-00287-y · Cited by 5
Adak, S., Jadhav, V. S., & Khatri, D. K. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01925-6 · Cited by 11
“These stem cells are able to repair tissue, regulate the immune response, and reduce inflammation, which is important in DR [181 ].”
Association of Physical Frailty and Genetic Predisposition with Risk of Irreversible Eye Diseases
Xu, Z., Lin, R., Wang, X., Liu, Y., Huang, C., Wang, C., & Bao, Z. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100910 · Cited by 4
IL-6 trans-signaling: an overlooked driver of retinal neovascularization?
Jung, M., Ness, J. N., Schwämmle, M. E., Rapp, J., Boneva, S., Groß, O., Mitschke, J., Schlunck, G., Agostini, H., Hannibal, L., et al. (2025) · Angiogenesis · doi:10.1007/s10456-025-10022-8 · Cited by 6
Oculomics and AI: The eye as a biomarker for health span
Wong, J. L. Y., Cheng, H., Peh, W. J., Ho, D., Wong, T. Y., Hui, C. Y. Y., Ting, D. S. J., Bee, Y. M., Goh, S., Apte, R. S., et al. (2026) · Asia-Pacific Journal of Ophthalmology · doi:10.1016/j.apjo.2026.100282 · Cited by 6
Tuli, N., Moroz, H., Jaffer, A., Kulbay, M., Tanya, S. M., Aslan, F. Ş., Ozdemir, D., Ali, S. K., & Qian, C. X. (2026) · Diagnostics · doi:10.3390/diagnostics16030392 · Cited by 7
“In DR, low-grade inflammation is prevalent, marked by elevated levels of several pro-inflammatory cytokines, including IL-1, IL-6, and TNF, detected in the aqueous and vitreous humour of patients with DR [141,142].”
Arreguín-Cano, J. A., Santana-Delgado, S. A., Villegas‐Mercado, C. E., Orozco-Molina, G. G., Gonzalez-Acosta, A., & Bermúdez, M. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1791782 · Cited by 7
Vitamin C alleviates hyperglycemic stress in retinal pigment epithelial cells
Alahmari, H., Liu, C.-C., Rubin, E., Lin, V. Y., Rodriguez, P., & Chang, K. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09595-2 · Cited by 5
Sang, W., Zhang, X., Hu, Q., Jiang, B., Guan, J., Huang, Z., Sun, L., & Sun, D. (2025) · Gene · doi:10.1016/j.gene.2025.149572 · Cited by 5
Zhang, X., Liu, Y., Xia, M., Yang, M., Wu, Y., & Zhang, F. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102182 · Cited by 4
“Elucidating this peripheral-retinal axis could enable glucose-independent early screening and precise interventions for DR. Current research on the molecular pathophysiology of DR indicates that retinal inflammation is a hallmark pathological feature of its early-stage [20].”
Zhang, D., Chen, S., Zhang, Y., Qiu, L., Du, M., Song, W., Guo, F., Zhang, J., Liu, X., & Yuan, H. (2025) · Advanced Science · doi:10.1002/advs.202507894 · Cited by 5
Potential of Human Neural Precursor Cells in Diabetic Retinopathy Therapeutics – Preclinical Model
Saçaki, C. S., Mogharbel, B. F., Stricker, P. E. F., Dziedzic, D. S. M., Irioda, A. C., Perussolo, M. C., Somma, A. T., Montiani‐Ferreira, F., Moreno, J. C. D., Dornbusch, P. T., et al. (2021) · Current Eye Research · doi:10.1080/02713683.2021.2002909 · Cited by 4
“Disorders caused by diabetes disrupt communication between neurons and glia.(6) The loss of neurovascular coupling in DR causes early retinal neurovascular unit impairment, gradual neurodegeneration, gliosis, and neuroinflammation.”
BackgroundThe role of vitamin D in the onset and progression of diabetic retinopathy
Totolici, G., Tiutiucă, C., Jurja, S., Tutunaru, D., & Pătrașcu, A.-M. (2022) · Romanian Journal of Ophthalmology · doi:10.22336/rjo.2022.42 · Cited by 4
“The destruction of the blood-retinal barrier leads to the appearance of exudates, haemorrhages and retinal edema [25,27].”
BackgroundWang, H., Su, X. W., Zhang, Q., Zhang, Y.-Y., Chu, Z.-Y., Sun, Z., Zhang, J., & Tang, Y.-F. (2022) · Current Eye Research · doi:10.1080/02713683.2022.2156548 · Cited by 4
“TUNEL-positive cells with the apoptotic cells distributed mainly in INL and GCL, which may be related to higher oxygen consumption and more hypoxia/ischemia of cells in the two layers.33 In addition, diabetes induced oxidative stress has been found to activate pro-apoptotic caspases and lower survival factor, which me…”
BackgroundInfluentialHernández, M., Recalde, S., Bezunartea, J., Moreno-Orduña, M., Belza, I., Chas, A., Perugini, E., García‐Layana, A., & Fernández‐Robredo, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158070 · Cited by 5
“…cells undergo several subcellular accumulated damages, such as an increase in lesions in DNA [23–25], mitochondrial accumulated damages, such as an increase in lesions in DNA [23–25], mitochondrial DNA degradation [26,27], cellular apoptosis [28,29], inflammation [30,31], and mitochondrial”
BackgroundRole of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration
Mu, J., Zhang, Z., Jiang, C., Geng, H., & Duan, J. (2025) · Journal of Ophthalmology · doi:10.1155/joph/3278794 · Cited by 5
Yang, J., Shin, S. J., Suh, J. K., Tchoe, H. J., Cho, S., Kang, M. J., & Jee, D. (2019) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2019.60.7.667 · Cited by 4
Balaban, J., Bijelić, R., Miličević, S., Stanetić, K., & Grbic, N. (2020) · Medical Archives · doi:10.5455/medarh.2020.74.443-448 · Cited by 4
“For decades, diabetic retinopathy was considered only a microvascular complication, but the microvascular structure of the retina is closely related and guided by neurons and glia, which are affected even before clinically visible vascular lesions and visual field problems in patients (18).”
Background
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.